Latest Breaking News On - Medical oncology - Page 5 : vimarsana.com

Nivolumab/Ipilimumab Bests Nivolumab in Ovarian and Extra-Renal Clear Cell Carcinomas

The combination of nivolumab and ipilimumab improved responses as well as survival outcomes in patients with ovarian or gynecologic clear cell carcinomas.

Nivolumab opdivoDons dizonPelvic malignancies programLifespan cancer instituteOncology sexual health first responders programHematology oncology outpatient clinicMedical oncologyRhode island hospital

ASCO 2024: Belzutifan in Patients with Advanced Clear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 2 LITESPARK-013 Study

ASCO 2024, advanced clear cell renal cell carcinoma (ccRCC), Belzutifan, LITESPARK-013 Study, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI).

United statesGeorgetown universityDistrict of columbiaMichael atkinsMichaelb atkinsUniversity of torontoGeorgetown lombardi comprehensive cancer centerDepartment of medical oncologyDatabase consortiumGeorgetown university medical centerMerck sharp domeSociety of urologic oncologyInternational metastaticAmerican society of clinical oncologyClinical oncologyAnnual meeting

Ultimovacs Announces Poster Presentation at the 2024

Ultimovacs Announces Poster Presentation at the 2024
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesPaul loriganUniversity of manchesterEuronext oslo stock exchangePoster sessionMedical oncology

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoHong kongNew yorkCaicun zhouWei liNuvation bioDepartment of oncology at shanghai east hospitalTongji universityDrug administrationNuvation bio incAnheart therapeutics ltdInnovent biologics incMedivation incChina national medical products administrationAmerican society of clinical oncology

Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Paul loriganUniversity of manchesterEuronext oslo stock exchangePoster sessionMedical oncologyOslo stock exchange